MONCTON, NB, Nov. 8, 2024 /CNW/ - Members of the media are invited to attend an important funding announcement for cancer research in New Brunswick.
BeiGene Canada, the country affiliate of global biotechnology company BeiGene will be announcing its support for two innovative cancer research projects through the BeiGene Canada Fund for Research and Innovation, a research fund that was designed to support research and innovation to address unmet needs and improve cancer care in Canada.
The announcement will be made at the Delta Moncton Beausejour as part of ResearchNB's annual Health Research Symposium, an event that puts the spotlight on health research happening in New Brunswick.
When:
Friday, November 15th, 2024 at 8:00 AM AST
Who:
Dr. Rodney J. Ouellette, Fund Recipient and Senior Researcher and Founder of the Atlantic Cancer Research Institute
Dr. Stephen M. Lewis, Fund Recipient and Scientific Director, of the Atlantic Cancer Research Institute
Peter Brenders, General Manager of BeiGene Canada
Pat Whalen, Chairperson, Research New Brunswick
Where:
Delta Moncton Beausejour
Room: Shediac C
750 Main Street
Moncton, NB
To RSVP to the event and/or to schedule an interview, please contact:
Stephanie Engel
[email protected]
(416) 846-6509
SOURCE BeiGene Canada
Share this article